---
title: "SYROS PHARMACEUTICALS, INC. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e6cb5d4a-35c3-5a56-ba2a-01639cd94f01
json: https://whiteintel.dev/api/public/dossier/e6cb5d4a-35c3-5a56-ba2a-01639cd94f01
identifier: lei:549300512PURS7IGVT96
jurisdiction: US-DE
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SYROS PHARMACEUTICALS, INC.

**Type:** Company  
**Jurisdiction:** US-DE  
**Identifier:** `lei:549300512PURS7IGVT96`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e6cb5d4a-35c3-5a56-ba2a-01639cd94f01  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e6cb5d4a-35c3-5a56-ba2a-01639cd94f01  

## Registry profile

- **Status:** LAPSED  
- **Legal form:** `XTIQ`  
- **Source:** GLEIF  

## Provenance

- GLEIF — https://search.gleif.org/#/record/549300512PURS7IGVT96

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SYROS PHARMACEUTICALS, INC.**. Human view: https://whiteintel.dev/entity/e6cb5d4a-35c3-5a56-ba2a-01639cd94f01 · Structured JSON: https://whiteintel.dev/api/public/dossier/e6cb5d4a-35c3-5a56-ba2a-01639cd94f01._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._